About this trial
Stroke is a leading cause of disability and with a heavy burden for the society. Despite the demands from 'Socialstyrelsen' of improving post-acute care, an effective structured follow-up to promote a patient-tailored rehabilitation remains largely lacking in the current stroke care.
The overall aim of this study is to find a cost-effective solution to facilitate patient-tailored rehabilitation that improves daily and social activities and health-related quality of life for persons discharged from the acute care after stroke. We have recently developed a novel digital graphic tool, Rehabkompassen®, which based on patient-reported outcome measurements captures the patient's complex health status after stroke.
Here, this tool will be used in a parallel, open-label, 2-arm prospective and multicenter pragmatic randomized controlled trial between 2022-2026. All participants (n = 1106) will be randomized according to permuted block design; and receive a usual care without (control group, n = 553) or with (intervention group, n = 553) Rehabkompassen®, within 3-month after stroke. The effectiveness of the tool on daily and social activities, quality of life and its health-economic effects will be compared at 12-month follow-up post stroke.
We hypothesize that the digital tool Rehabkompassen® will provide a patient-tailored rehabilitation that improves recovery, independence, and quality of life among people with stroke in a cost-effective way.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18 years or older.
With a stroke diagnosis
Disqualifiers
Unable to answer the evaluation questions.
Unable to see the Rehabkompassen®graph.
Not using BankID, an e-identification tool commonly used in Sweden.
Trial design
Parallel
Treatments tested in this trial
a usual follow-up with Rehabkompassen®
Other interventionRehabkompassen® is a patient-centered digital graphic tool for capturing the patient's rehabilitation needs in the follow-up after stroke.
a usual follow-up with Post-Stroke Checklist, i.e. without Rehabkompassen®
Other interventionPost-Stroke Checklist consists of eleven questions concerning common and treatable post-stroke problems affecting quality of life.
Treatment groups
Trial outcomes
Primary outcomes
Daily activities
The simplified modified Rankin Scale questionnaire (smRSq) will be used to measure daily activities and functional status. The smRSq is based on the yes/no responses to five questions, which in turn results an ordinal data of seven categories (0-6) of the modified Rankin Scale. A favorable outcome will be defined as mRS score of 0-2 (no symptoms to independent but with minor disability). A poor outcome will be defined as mRS score of 3-5 (disability but able to walk to bed-bound and in need of full nursing care) or 6 (death).
Social activities
Stroke Impact Scale 3.0 (SIS)-participation (SIS-p) will be used to measure social activities. SIS-p is the dominant problem among persons after stroke reported in previous Swedish stroke RCTs; but not covered by smRSq. The SIS-p score ranges from 0-100 and the higher the score the less impact of stroke.
Secondary outcomes
Health-related quality of life
Health-related quality of life will be measured by five-level EuroQoL 5-dimension (EQ- 5D-5L) at both follow-ups in all participants. EQ-5D is a validated instrument that has often been used in RCTs. It consists of two parts: a visual analogue scale and a descriptive system covering five dimensions of health (mobility, hygiene, usual activities, pain/discomfort, and anxiety/depression) with five response alternatives (ranging from no problems to extreme problems). The latter can be translated to index value with anchor points 0 (death) and 1 (full health), which corresponds to a QALY score.
Stroke impacts
Stroke impacts will be assessed by the Stroke Impact Scale 3.0 (SIS) except the participation domain. SIS is a patient-reported, stroke-specific, outcome measurement containing 59 questions with eight domains, namely strength, memory/ cognition, feelings/ emotions, communication, personal activities of daily living (ADL), instrumental ADL, mobility, and motor impact. Each question is answered using the Likert scale ranging from 1 to 5 with higher scores indicating better outcomes. Also, the SIS includes a visual analogue scale where 0 represents no perceived stroke recovery and 100 represents full recovery.
Health-economic evaluation
The cost-effectiveness will be assessed in term of the quality-adjusted life year (QALY), that will be calculated by the utilities multiplying the time spent in each health state.
Clinicians' usability
System usability scale consists of a 10-item questionnaire with five response options for respondents from strongly agree to strongly disagree.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Umeå University
Lead sponsor
The Swedish Research Council
Collaborator
Forte: Swedish research council for health, working life and welfare
Collaborator
Swedish Heart Lung Foundation
Collaborator
Vinnova
Collaborator
Strokeförbundet
Collaborator
Västerbotten County Council, Sweden
Collaborator
Göteborg University
Collaborator
Vastra Gotaland Region
Collaborator
Uppsala University
Collaborator
Uppsala County Council, Sweden
Collaborator
Karolinska Institutet
Collaborator
Region Stockholm
Collaborator
Västmanland County Council, Sweden
Collaborator
Värmland County Council, Sweden
Collaborator
Sormland County Council, Sweden
Collaborator
Region Skane
Collaborator